September 23, 2021

Top Challenges to Overcome When Developing AAV Processes: Part 1 of 2

In the first of a two-part series, Anki Magnusson, Staff Research Engineer, Protein and Viral Production, and Åsa Hagner-McWhirter, PhD, Senior Scientist, Bioprocess Applications R&D, both at Cytiva, explore obstacles faced during adeno-associated virus (AAV) process development from both the upstream and downstream perspective.

Tags: AAV; adeno-associated virus; process development; upstream; downstream